Fundraising Fox

Xilio Therapeutics

NASDAQ: XLO

Waltham, US · Founded 2020 · Delaware corporation · 10 known investors

xiliotx.com ↗
Biotechin /xilio-tx

Founders & leadership

PC
Paul ClancyDirector
DC
Daniel CurranDirector
PD
Peter DudekDirector
DG
David GrayzelDirector
NH
Nancy HongDirector
RH
Rachel HumphreyDirector
DL
Daniel LynchDirector
MR
Michael RossDirector
RW
Robert WeisskoffDirector
JF
Joseph FarmerExecutive Officer
RR
Rene RussoExecutive Officer, Director
TC
Timothy ClacksonExecutive Officer

Investors · 10

Bain Capital Life SciencesBostonvia Andrew Hack · board
Bay City CapitalSan Rafael · $5M – $10M
M VenturesLos Angeles · $10.8M
MRL Ventures FundCambridge · $25M
RA CapitalBoston
RiverVest Venture PartnersSt. Louis · $500K – $3M
Solasta VenturesBoston
SV Health InvestorsBoston · $1M – $20M
Atlas VenturereportedCambridge · $500K – $1Mvia David Grayzel · board
F-Prime Capital PartnersreportedCambridge · $3M – $10Mvia Robert Weisskoff · board

Reported raises · per SEC filings

Form D private placements
▶$95MraisedFeb 2021 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Rachel HumphreyDirector
  • Andrew HackDirector
  • David GrayzelDirector
  • Daniel LynchDirector
  • Michael RossDirector
  • Joseph FarmerExecutive Officer
  • Rene RussoExecutive Officer, Director
  • Timothy ClacksonExecutive Officer
  • Paul ClancyDirector
  • Daniel CurranDirector
  • David GardnerDirector
Offering amount
$95M
Amount sold
$95M
First sale
Feb 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$50.2MraisedJan 2021 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul ClancyDirector
  • Daniel CurranDirector
  • Peter DudekDirector
  • David GrayzelDirector
  • Nancy HongDirector
  • Rachel HumphreyDirector
  • Daniel LynchDirector
  • Michael RossDirector
  • Robert WeisskoffDirector
  • Joseph FarmerExecutive Officer
  • Rene RussoExecutive Officer, Director
  • Timothy ClacksonExecutive Officer
Offering amount
$50.2M
Amount sold
$50.2M
First sale
Jan 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.